Presentation and management of delayed aortic endograft infection

BMJ Case Rep. 2023 Mar 10;16(3):e252924. doi: 10.1136/bcr-2022-252924.

Abstract

A man in his 60s who underwent endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm 4 years ago presents with 1 week of abdominal pain, fever and leucocytosis. CT angiogram demonstrated an enlarged aneurysm sac with intraluminal gas and periaortic stranding consistent with infected EVAR. He was clinically unfit for an open surgical intervention due to his significant cardiac comorbidities, including hypertension, dyslipidaemia, type 2 diabetes, recent coronary artery bypass grafting and congestive heart failure secondary to ischaemic cardiomyopathy with an ejection fraction of 30%. Therefore, due to this significant surgical risk, he was treated with percutaneous drainage for the aortic collection and lifelong antibiotics. The patient is well 8 months following presentation with no signs of ongoing endograft infection, residual aneurysm sac enlargement, endoleak or haemodynamic instability.

Keywords: Infectious diseases; Interventional radiology; Vascular surgery.

Publication types

  • Case Reports

MeSH terms

  • Aortic Aneurysm, Abdominal* / surgery
  • Blood Vessel Prosthesis Implantation*
  • Diabetes Mellitus, Type 2* / surgery
  • Endoleak
  • Endovascular Procedures*
  • Humans
  • Male
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome